Tempus AI signals beyond the news: 70+ signals from 7 sources
The latest Tempus AI signal on this page is from Oct 27, 2026 (Patents): "Tempus AI was granted a patent for extracting clinical phenotypes from notes." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).
Public (TEM)Biotechnology Research5,001 to 10,000 employeestempus.comLinkedIn
Get Tempus AI's live signals in Claude or ChatGPT, or by API
What changed at Tempus AI this week? Use Autobound signals for tempus.com.- Signals
- 70+
- Sources
- 7
- Last 90 days
- 27
- Latest
- Oct 27, 2026
Source: Autobound Signal API · 98 signals tracked for Tempus AI · updated
Other signals · latest 10
Latest Tempus AI signals by source
70+ signals for Tempus AI across 7 sources.
Patents · Patent grant
Tempus AI was granted a patent for extracting clinical phenotypes from notes.
In October 2026 Tempus AI patented natural-language processing for identifying condition-related information in unstructured EHR and EMR notes for clinical data analysis.
- Patent title
- Phenotyping of clinical notes using natural language processing models
- Grant date
- Oct 27, 2026
- Inventors
- William E. Thompson, IV, David Michael Vidmar, RuiJun Chen
- Tech area
- health tech / medical informatics
Patents · Patent pace
TEMPUS AI, INC.'s patent output is slowing: 24 grants in the past year, 1 in the past 30 days.
Over the past year TEMPUS AI, INC. received 24 US patent grants, concentrated in health tech / medical informatics and software / computing; the recent pace (7 in 90 days) is slowing versus its trailing baseline.
- Grants, 12 months
- 24
- Grants, 90 days
- 7
- Grants, 30 days
- 1
- Pace
- Decelerating
Glassdoor · Compensation dissatisfaction
Employees report low associate pay and compensation below market rate
Multiple reviewers mention that associate pay is tough and compensation is slightly under market rate, impacting overall satisfaction.
- Overall rating
- 3.1 of 5
- CEO approval
- 44%
- Reviews read
- 9
- Review window
- Sep 11, 2026 to Oct 10, 2026
Glassdoor · Engineering culture issues
Senior Software Engineer describes terrible engineering culture plagued by politics and incompetence
A Senior Software Engineer reports an engineering culture rife with politics and incompetence, criticizing non-engineers in leadership roles and bureaucratic processes that hinder progress.
- Overall rating
- 3.1 of 5
- CEO approval
- 44%
- Reviews read
- 9
- Review window
- Sep 11, 2026 to Oct 10, 2026
Product reviews · Pricing concerns
Verified User reports Tempus is expensive to use despite being cost-effective
A Verified User in Computer & Network Security at a Small-Business company notes that Tempus is expensive to use, although they deem it cost-effective overall. This indicates a potential barrier for some users or a concern regarding the cost-to-value ratio.
- Star rating
- 4 of 5
- Reviewer
- Verified User in Computer & Network Security
- Reviewer details
- Small-Business (50 or fewer emp.)
Reddit · Acquisition announced
Tempus has an agreed buyout offer to acquire Personalis at $16.25 per share, which is pending shareholder approval.
Post: "PSNL - a textbook case of reflexivity from Soros’ Alchemy of Finance?"
- Subreddit
- r/wallstreetbets
- Upvotes
- 1
- Comments
- 0
- Sentiment
- Neutral
LinkedIn
Tempus CEO discusses unified stack for drug development with AI integration.
In a new article, our CEO of Data & Apps, Ryan Fukushima, shares his perspective on why drug development requires a unified stack • Proprietary Multimodal Data to capture actual biology • Tailored AI Models & Agents to perform multi-step scientific reasoning • High-Performance Compute brought directly to the data...
- Likes
- 47
- Comments
- 1
- Tags
- Artificial Intelligence, Product Development, Research & Development, Pharmaceuticals
- Initiatives
- integrating AI into drug development platform
Product reviews · Missing features
SREs report Tempus lacks customization for dashboards, reporting, and workflow automation
Atharva S., an SRE at a mid-market company, expresses a need for more customization for dashboards, reporting, and workflow automation. A Verified User from a mid-market internet company also desires more customization options for dashboards and data visualizations.
- Star rating
- 4.5 of 5
- Reviewer
- Atharva S.
YouTube
Tempus AI 60% Rocket! Buy TEM Stock Now! TEM Stock Analysis
Ez Money Show analyzes Tempus AI stock, discussing its potential as a portfolio investment.
- Channel
- Ez Money Show
- Views
- 23
- Comments
- 0
- Tags
- Stock Analysis, Biotechnology, Precision Medicine
Website changes · Product launch
No new products, services, or major feature launches are indicated in the recent website update.
The content remains focused on existing solutions, clinical data, and integration capabilities without mention of new offerings.
- Page
- /oncology
Showing 10 of 70+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Tempus AI with the Signal API
One POST /v1/companies/enrich call with tempus.com returns Tempus AI signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "tempus.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Company pages
Other signals at related companies
Questions about Tempus AI other signals
What signals does Autobound track for Tempus AI besides news and filings?
What are people saying about Tempus AI online?
What do employees say about working at Tempus AI?
Has Tempus AI been granted patents recently?
Page updated , the date of the newest row on this page.
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .